2-[(3-氯-2-甲基苯基)硫代]乙酸 | 6375-67-3

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 中文名称: 2-[(3-氯-2-甲基苯基)硫代]乙酸
• 英文名称: (3-chloro-2-methyl-phenylsulfanyl)-acetic acid
• 英文别名: (3-Chlor-2-methyl-phenylmercapto)-essigsaeure；S-(3-Chlor-2-methyl-phenyl)-thioglykolsaeure；2-[(3-Chloro-2-methylphenyl)thio]acetic acid；2-(3-chloro-2-methylphenyl)sulfanylacetic acid
• CAS: 6375-67-3
• 化学式: C₉H₉ClO₂S
• 分子量: 216.688
• InChiKey: MYYDJXQRXGECKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  62.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-[(3-氯-2-甲基苯基)硫代]乙酸 在 三氯化磷 作用下， 生成 6-chloro-7-methyl-benzo[b]thiophen-3-ol
  参考文献：
  名称：

  DE494948

  摘要：

  公开号：
• 作为产物：
  描述：

  potassium ethyl xanthogenate 、 alkaline earth salt of/the/ methylsulfuric acid 生成 2-[(3-氯-2-甲基苯基)硫代]乙酸
  参考文献：
  名称：

  Gindraux, Helvetica Chimica Acta, 1929, vol. 12, p. 932

  摘要：

  DOI：

文献信息

• PYRIMIDINE OR TRIAZINE FUSED BICYCLIC METALLOPROTEASE INHIBITORS
  申请人：Alantos Pharmaceuticals, Inc.

  公开号：EP1910367A2

  公开（公告）日：2008-04-16
• Heterobicyclic metalloprotease inhibitors
  申请人：Steeneck Christoph

  公开号：US20060293345A1

  公开（公告）日：2006-12-28

  The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 inhibitors.
• Heterobicyclic Metalloprotease Inhibitors
  申请人：STEENECK Christoph

  公开号：US20090312312A1

  公开（公告）日：2009-12-17

  The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
• HETEROBICYCLIC METALLOPROTEASE INHIBITORS
  申请人：Steeneck Christoph

  公开号：US20120015920A1

  公开（公告）日：2012-01-19

  The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
• US7795245B2
  申请人：——

  公开号：US7795245B2

  公开（公告）日：2010-09-14